Roquefort Therapeutics PLC (LON: ROQ) has agreed to sell its subsidiary, Oncogeni, to UAE-based Nations Trust Holding in a deal worth up to $12 million (£9.3 million).
Traders Cafe with Zak Mir: Bulletin Board Heroes, Thursday 31st October 2024
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Pound/Dollar, Avacta
Share Talk Weekly Small Cap Movers & Shakers, Saturday 25th May 2024
The FTSE 100 declined by 0.2%. Ocado led the gainers, increasing by 6.2%, with Marks & Spencer next, rising by 2.3%. National Grid saw the largest drop, falling by 11.5%,
Roquefort Therapeutics plc (LSE:ROQ,OTCQB:ROQAF) Midkine Antibody Licencing Deal
Roquefort Therapeutics plc (LSE: ROQ, OTCQB: ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth immuno-oncology market is pleased to announce